0001685428-20-000005.txt : 20200528 0001685428-20-000005.hdr.sgml : 20200528 20200528164956 ACCESSION NUMBER: 0001685428-20-000005 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200528 DATE AS OF CHANGE: 20200528 EFFECTIVENESS DATE: 20200528 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LumiraDx Ltd CENTRAL INDEX KEY: 0001685428 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-364337 FILM NUMBER: 20921879 BUSINESS ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2AQ BUSINESS PHONE: 011 44 1786 430411 MAIL ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2AQ D/A 1 primary_doc.xml X0708 D/A LIVE 0001685428 LumiraDx Ltd 3 MORE LONDON RIVERSIDE LONDON X0 UNITED KINGDOM SE1 2AQ 011 44 1786 430411 CAYMAN ISLANDS None None Other Exempted company limited by shares true 2016 Ron Zwanziger c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Director David Scott c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Director Jerry McAleer c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Director David Walton c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Nigel Lindner c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE1 2AQ Executive Officer Peter Welch c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Veronique Ameye c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Tom Quinlan c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Peter Scheu c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Dorian LeBlanc c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Donald Berwick c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Bruce Keogh c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Lurene Joseph c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Lu Huang c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Troyen Brennan c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Suresh Vazirani c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Other Health Care Decline to Disclose 06b true 0001685428-20-000004 2020-03-28 false true true true false 1000000 U.S. Boston Capital Corporation 5251 None None 55 Old Bedford Road Lincoln MA MASSACHUSETTS 01773 All States false 150000000 150000000 0 Amount sold shown in item 13 and number of investors in item 14 includes $62,400,000 from eight non-US investors. false 118 1050000 true 0 US Boston Capital Corp. receives an administrative fee and a placement fee based on amount sold. A portion of the fee may be paid in convertible notes. 0 false LumiraDx Ltd /s/Dorian LeBlanc Dorian LeBlanc CFO 2020-05-28